Dafna D Gladman

Dafna D Gladman, MD, FRCPC

Prognosis, genetic and theraupeutic studies in the rheumatic diseases particularly:
  • Psoriatic arthritis
  • Systemic lupus erythematosus
  • Rheumatoid arthritis

Related Links

Lupus. 2016 Aug 13;
Cramarossa G, Urowitz MB, Su J, Gladman D, Touma Z
J Clin Rheumatol. 2016 Aug;22(5):287-8
Tselios K, Gladman DD, Harvey P, Mak S, Chantal M, Butany J, Urowitz MB
J Rheumatol. 2016 Jul 15;
Sheane BJ, Thavaneswaran A, Gladman DD, Chandran V
Arthritis Rheumatol. 2016 Jul 7;
Abji F, Pollock RA, Liang K, Chandran V, Gladman DD
Semin Arthritis Rheum. 2016 May 25;
Chandran S, Aldei A, Johnson SR, Cheung AM, Salonen D, Gladman DD
Arthritis Care Res (Hoboken). 2016 May 23;
Sheane BJ, Gladman DD, Su J, Urowitz MB
Arthritis Care Res (Hoboken). 2016 Feb;68(2):267-74
Kavanaugh A, van der Heijde D, Beutler A, Gladman D, Mease P, Krueger GG, McInnes IB, Helliwell P, Coates LC, Xu S
J Rheumatol. 2016 May;43(5):986-9
Gladman DD, Mease PJ, Boehncke WH, Helliwell PS, Callis Duffin K
J Rheumatol. 2016 May;43(5):979-85
Mease PJ, Helliwell PS, Boehncke WH, Coates LC, FitzGerald O, Gladman DD, Deodhar AA, Callis Duffin K
J Rheumatol. 2016 May;43(5):970-3
de Wit M, Campbell W, Coates LC, Gladman DD, James J, Lindsay CA, MacDonald R, Moverley AR, Ogdie A, Orbai AM, O'Sullivan D, Parkinson A, Steinkoenig I, Tillett W, Goel N

Pages


 

Deputy Director, Centre for Prognosis Studies in the Rheumatic Diseases (part of the UHN Arthritis and Autoimmunity Research Centre)
Co-Director, Lupus Clinic, Toronto Western Hospital (TWH)
Director, Psoriatic Arthritis Program, TWH